Clover Health Investments Corp (CLOV) Stock Analysis

Verdict: HOLD

CLOV's turn to quarterly EPS profitability fuels upside, but persistent cash burn and zero insider buying limit long-term conviction.

Investment score: 55/100

Analysis as of 2026-09-10

Is Clover Health Investments Corp stock worth reviewing? AI model thesis

The model assigns CLOV a HOLD rating with an investment score of 55/100, highlighting operational improvements alongside remaining balance sheet risks.

7-factor investment score

Valuation: 45/100 (weight 20%)
Financial Health: 52/100 (weight 15%)
Technical Momentum: 78/100 (weight 15%)
Earnings Quality: 72/100 (weight 15%)
Insider Sentiment: 20/100 (weight 10%)
Analyst Consensus: 65/100 (weight 10%)
Risk-Adjusted Return: 48/100 (weight 15%)

Clover Health Investments Corp opportunities and risks

What speaks for CLOV

Consecutive Quarterly EPS Profitability

What speaks against CLOV

Depleting Cash Reserves and Burn Rate

Peers and competitors

Trailing-twelve-month ratios
Ticker	P/E	P/S	EV/EBITDA	Gross margin	Net margin	FCF yield
CLOV	n/a	1.0x	n/a	18.6%	-0.7%	3.0%
HUM	37.9x	0.3x	18.2x	13.7%	0.9%	-0.9%
CNC	n/a	0.2x	n/a	16.1%	-2.6%	27.7%
MOH	1241.2x	0.2x	25.2x	34.6%	-0.0%	2.6%
HQY	33.4x	5.7x	18.2x	75.2%	17.4%	6.0%
ALHC	65.0x	0.6x	26.9x	12.5%	0.9%	7.6%
Peer median	37.9x	0.3x	18.2x	16.1%	0.9%	6.0%

Frequently asked questions about Clover Health Investments Corp (CLOV)

Is CLOV stock a good investment?

The cached TradeMates AI model rates Clover Health Investments Corp as HOLD with an investment score of 55/100. The model assigns CLOV a HOLD rating with an investment score of 55/100, highlighting operational improvements alongside remaining balance sheet risks. This is algorithmic model output, not personal investment advice.

Is CLOV stock a buy?

The TradeMates model verdict for CLOV is HOLD with an investment score of 55/100. Treat this as a model signal to review, not a personal buy recommendation.